Study Results from Mayo Clinic Provide New Insights into Clinical Biochemistry (Using Differential Mobility Spectrometry To Improve the Specificity of Targeted Measurements of 2,3-dinor 11b-prostaglandin F2a)

MLA

“Study Results from Mayo Clinic Provide New Insights into Clinical Biochemistry (Using Differential Mobility Spectrometry To Improve the Specificity of Targeted Measurements of 2,3-Dinor 11b-Prostaglandin F2a).” Health & Medicine Week, 24 May 2024, p. 6654. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.794378751&authtype=sso&custid=ns315887.

APA

Study Results from Mayo Clinic Provide New Insights into Clinical Biochemistry (Using Differential Mobility Spectrometry To Improve the Specificity of Targeted Measurements of 2,3-dinor 11b-prostaglandin F2a). (2024, May 24). Health & Medicine Week, 6654.

Chicago

Health & Medicine Week. 2024. “Study Results from Mayo Clinic Provide New Insights into Clinical Biochemistry (Using Differential Mobility Spectrometry To Improve the Specificity of Targeted Measurements of 2,3-Dinor 11b-Prostaglandin F2a),” May 24. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.794378751&authtype=sso&custid=ns315887.